The Charles Seller Foundation is delighted to announce our 2022 Beneficiary, Chase McGee!

Meet our 2022 beneficiary, Chase McGee!

Chase was diagnosed in August of 2021 with Medulloblastoma. Medulloblastoma is a cancerous brain tumor that starts in the lower back part of the brain. Chase is 1 of three children, with 2 younger siblings. Despite his diagnosis and the challenges that come with it, Chase and his family manage it all with a positive attitude!